등급 & 순도Moligand™?Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools.≥98%
Lazabemide is a reversible and selective inhibitor of monoamine oxidase B (MAO-B) with Ki value of 7.9 nM.
사양
동의어
5-Chloro-pyridine-2-carboxylic acid (2-amino-ethyl)-amide | LAZABEMIDE [USAN] | 2-Pyridinecarboxamide, N-(2-aminoethyl)-5-chloro- | n-(2-aminoethyl)-5-chloro-2-pyridinecarboxamide | N-(2-Aminoethyl)-5-chloro-2-pyridinecarboxamide hydrate | LAZABEMIDE [MART.] | N-(2-Aminoethyl)-5-chloropicolinamide | Ro 19-6327 hydrate | Carbamic acid, eth Show more
사양 및 순도
Moligand™, ≥98%
생화학 및 생리적 메커니즘
Lazabemide (Ro 19-6327) is a selective and reversible inhibitor of monoamine oxidase B (MAO-B) (IC50=0.03 μM), but less active against MAO-A (IC50>100 μM). High concentrations of Lazabemide have inhibitory effects on monoamine uptake, with IC50 values of 86 μM, 123 μM and >500 μM for norepinephrine, serotonin and dopamine uptake, respectively. Lazabemide can be used in Parkinson's and Alzheimer's disease research.
This compound belongs to the class of organic compounds known as pyridinecarboxamides. These are compounds containing a pyridine ring bearing a carboxamide.
External Descriptors
Not available
1. Djoumbou Feunang Y, Eisner R, Knox C, Chepelev L, Hastings J, Owen G, Fahy E, Steinbeck C, Subramanian S, Bolton E, Greiner R, and Wishart DS. ClassyFire: Automated Chemical Classification With A Comprehensive, Computable Taxonomy. Journal of Cheminformatics, 2016, 8:61.
Products are supplied to verified businesses, institutions, and qualified professionals for research and development use only. Not for use in humans, animals, diagnosis, or therapy.